Corium Presents Full Clinical Results from Phase 1 Pharmacokinetic Study of Once-weekly Corplex™ Donepezil Transdermal System
July 27, 2016 16:01 ET
|
Corium International, Inc.
MENLO PARK, Calif., July 27, 2016 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium to Present Clinical Data from a Phase 1 Pharmacokinetic Study of Once-Weekly Corplex™ Donepezil Transdermal System
July 20, 2016 16:03 ET
|
Corium International, Inc.
MENLO PARK, Calif., July 20, 2016 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
July 05, 2016 16:20 ET
|
Corium International, Inc.
MENLO PARK, Calif., July 05, 2016 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium to Present at the Jefferies 2016 Healthcare Conference
May 25, 2016 16:05 ET
|
Corium International, Inc.
MENLO PARK, Calif., May 25, 2016 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Reports Second Quarter Fiscal 2016 Financial Results and Recent Corporate Highlights
May 10, 2016 16:03 ET
|
Corium International, Inc.
MENLO PARK, Calif., May 10, 2016 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium to Report Second Quarter Fiscal Year 2016 Financial Results on Tuesday, May 10, 2016
May 03, 2016 16:05 ET
|
Corium International, Inc.
MENLO PARK, Calif., May 03, 2016 (GLOBE NEWSWIRE) -- Corium International, Inc. (NASDAQ:CORI) today announced that it will report financial results for the second fiscal quarter ended March 31,...
Corium Announces Streamlined Bioequivalence Development Path for Transdermal Corplex™ Donepezil Following Positive Pre-IND Communication from FDA
May 02, 2016 16:05 ET
|
Corium International, Inc.
Reports Positive PK Results from Clinical Study of Optimized Once-weekly Corplex Donepezil for Alzheimer’s Disease MENLO PARK, Calif., May 02, 2016 (GLOBE NEWSWIRE) -- Corium...
Corium to Present at 15th Annual Needham Healthcare Conference
March 31, 2016 08:00 ET
|
Corium International, Inc.
MENLO PARK, Calif., March 31, 2016 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Announces Positive Preclinical Results with Long-acting Potent GLP-1 Analog Delivered in MicroCor® Transdermal Patch
March 29, 2016 16:03 ET
|
Corium International, Inc.
MENLO PARK, Calif., March 29, 2016 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and...
Corium Announces Positive Topline Results From Phase 1 Clinical Study of Transdermal Corplex™ Memantine as a Potential Treatment of Alzheimer’s Disease
February 22, 2016 16:03 ET
|
Corium International, Inc.
Demonstrates Pharmacokinetic Profile Supporting the Feasibility of Sustained Transdermal Delivery Webcast and Conference Call Today at 5:00 p.m. ET (2:00 p.m. PT) MENLO PARK, Calif., Feb. ...